(Q39759735)

14 September 2017

title

Therapeutic angiogenesis by intramuscular injection of fibrin particles into ischaemic hindlimbs (English)

1 reference

14 September 2017

Chun-Ling Fan

1

1 reference

14 September 2017

Ping-Jin Gao

2

1 reference

14 September 2017

Yuan-Jun Gu

3

1 reference

14 September 2017

Xiao-Feng Tang

4

1 reference

14 September 2017

Jian-Jun Liu

5

1 reference

14 September 2017

Jian Wei

6

1 reference

14 September 2017

Kazutomo Inoue

7

1 reference

14 September 2017

Ding-Liang Zhu

8

1 reference

14 September 2017

publication date

1 July 2006

1 reference

Clinical and Experimental Pharmacology and Physiology

14 September 2017

published in

1 reference

14 September 2017

volume

33

1 reference

14 September 2017

issue

7

1 reference

14 September 2017

page(s)

617-622

1 reference

Mechanisms of angiogenesis

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04416.X

Gene transfer as a tool to induce therapeutic vascular growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04416.X

Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04416.X

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04416.X

Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04416.X

Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04416.X

Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04416.X

Wound repair in the context of extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04416.X

Blood vessel formation: what is its molecular basis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04416.X

Myocardial angiogenesis and coronary perfusion in left ventricular pressure-overload hypertrophy in the young lamb. Evidence for inhibition with chronic protamine administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04416.X

Clinical applications of fibrin sealants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04416.X

Direct fibrin injection to promote new collateral growth in hind limb ischemia in a rabbit model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04416.X

Thrombin induces angiogenesis and vascular endothelial growth factor expression in human endothelial cells: possible relevance to HIF-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04416.X

Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04416.X

Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04416.X

Intraventricular infusion of vascular endothelial growth factor promotes cerebral angiogenesis with minimal brain edema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04416.X

Therapeutic potential of endothelial progenitor cells for cardiovascular diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04416.X

Endothelial progenitor cells for postnatal vasculogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04416.X

Fibrin-enhanced endothelial cell organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04416.X

10.1111/J.1440-1681.2006.04416.X

21 January 2018

Identifiers

DOI

1 reference

14 September 2017

1 reference